Navigation Links
The science of design
Date:4/9/2009

Some women would kill for a great pair of Manolos. Some men would easily pay more than $100 for a pair of Jordans. But what about a new pair of McGuire and Whitneys?

Temple podiatrists James McGuire and Kendrick Whitney recently joined the shoe design business with the release of their R'n'R rest and recovery shoe, the first commercially available shoe to be designed by university-backed researchers.

The R'n'R is a product of Creative Footwear Technology, a venture between the two doctors and local entrepreneur Richard Posoff that uses the latest in foot and ankle research to produce a foot-friendly therapeutic shoe.

"Most shoes on the market today are designed by artists and not scientists who know something about how the foot works," said McGuire. "Our goal was to enhance the way shoes are designed, by looking at research-based findings and put out a better shoe, one that's designed with both function and form in mind."

Commercially available shoes tend to place the most support on the arch of the foot, which throws off the body's center of gravity and keeps the foot from functioning normally. McGuire and Whitney say that the R'n'R offers an entirely new way to support the arch, and it dissipates the shock and stress experienced at the two most stressful parts of the gait cycle: heel strike and pushoff. As a result, the shoes provide a more natural gait, reduce shock and shear forces, and support the foot while still allowing a natural use of the muscles and bones.

Whitney said the shoe is a reflection of the industry's shift away from orthotic inserts that are designed to restrict foot movement.

"We want the foot to work normally, as if it was a bare foot, as nature intended," he said. "This shoe is designed to allow for a more natural function with enhanced comfort for a harsh environment."

Together, McGuire and Whitney have developed more than 30 footwear and foot care products to meet their patients' needs, but the R'n'R is their first to be sold over the counter in retail stores.

Temple's Office of Strategic Initiatives and Corporate Partnerships facilitated the business partnership, with due diligence and business plan advice provided by BioStrategy Partners in Philadelphia. Market research and business plan assistance was provided by the Fox School of Business.

"Creative Footwear Technology represents another example of Temple's commitment to support entrepreneurial efforts by its faculty," said Larry Lemanski, the university's senior vice president for research and strategic initiatives. "The company's partnership with our Office of Technology Transfer, Office of Strategic Initiatives and Corporate Partnerships, the Fox School of Business and BioStrategy Partners demonstrates how society can benefit when industry and academia work together in applying scientific findings to solve real-life problems."


'/>"/>

Contact: Renee Cree
rencree@temple.edu
215-707-1583
Temple University
Source:Eurekalert  

Related medicine news :

1. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
2. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
3. Edwards Lifesciences to Present at the Bear Stearns 20th Annual Healthcare Conference
4. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
5. HealthFitness CEO Supports Move Toward Cultural Shift, and Science-Based Health Management Programming
6. Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference
7. John B. Buse, MD, PhD of Chapel Hill, NC, Elected American Diabetes Association President, Medicine & Science
8. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
9. SAMHSA Announces First Science and Service Award Winners
10. Novavax CEO to Present at the 2007 UBS Global Life Sciences Conference
11. Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
The science of design
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
Breaking Medicine Technology: